Erasca, Inc.: financial statements

ERASNASDAQHealthcare · Pharmaceutical Preparations

Price

$13.61

November 20, 2026Market cap $4.8B

What Ploutos Investor adds for Erasca

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 6 fiscal years, from 2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Financial statements

Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.

2023–2025 fiscal years

Click a line to see it on the chart.

Operating income

Line202320242025Average a year
Operating income -$142M-$180M-$141M
Net income -$125M-$162M-$125M
Earnings per share -$0.83-$0.69-$0.44
Earnings per share, basic -$0.83-$0.69-$0.44

Financial statements

ERAS's revenue, profits and cash flows from 2020 to 2022, 3 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.

Debt and obligations

What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.

$47M Leases0.0% Effective tax rate

Leases

Dec 31, 2025

Operating leases

$47M

Finance leases

–

Average discount rate
9.0%
Lease cost for the year
$7.3M

The liability is the present value of the rent still to pay, at December 31, 2025. It is not counted in the ladder's debt. The filing

Operating lease payments by year

Lease liability by year

Leases

ERAS's leases from 2021 to 2022, 2 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

From the statutory to the effective tax rate, 2025

Dec 31, 2025

Statutory rate

21.0%

Effective rate

0.0%

-21.0 pts

The company paid 0.0% in tax on its profit, 21.0 points below the US federal rate (21.0%). Below, the reasons it gives.

Statutory rate

21.0%

Tax credits

+2.7 pts

Change in valuation allowance

-19.6 pts

Executive pay deduction limit

-1.7 pts

Share-based compensation

-1.6 pts

Uncertain tax positions

-0.5 pts

Non-deductible expenses

-0.3 pts

Effective rate

0.0%

One point is 1% of profit before tax. The lines are as the company states them in the notes to its annual report. The filing

Effective tax rate by year

Effective tax rate by year

The tax rate ERAS paid on its profit, from 2020 to 2022, 3 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Claims ahead of shareholders

What stands between the business and its shareholders besides the debt, and the financial assets on the other side, from the latest balance sheet.

$304M securities and stakes

Besides its debt, no other claim large enough to list ranks ahead of the shares.

On the other side, it holds $304M of long-term securities and stakes in other companies, at the value in its accounts, about 6.4% of the market value.

On the other side

at Sep 30, 2026
$304M

From the balance sheet of September 30, 2026. The retirement and environmental lines and the pension deficit come from the latest annual report when the quarter's filing does not state them, each with its own date. Market value at the price of November 20, 2026. A line is listed when it is at least 0.5% of the market value. A description of the balance sheet, not a valuation.

The metrics a company reports about itself (users, stores, subscribers) are read for S&P 500 companies only.

The full analysis

What do Erasca's filings show?

These are Erasca's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about ERAS's financials

Didn't find what you were looking for?

Ask us
How much debt does ERAS have?

On December 31, 2025 Erasca had total assets of $396M, debt of – and shareholders' equity of $325M.

How much free cash flow does ERAS have?

In fiscal 2025 Erasca had cash from operations of -$95M and spent $128.0K on capital expenditure, leaving -$96M of free cash flow.

Where are the figures from?

From Erasca, Inc.'s annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.